ctDNA Tracks Relapse Risk in Breast Cancer
June 9, 2026
Personalized liquid biopsy testing identified molecular residual disease months before clinical recurrence
2 min read
False
June 9, 2026
Personalized liquid biopsy testing identified molecular residual disease months before clinical recurrence
2 min read
June 4, 2026
By Helen Bristow
A patented AI platform trained on NYU Langone research is predicting cancer mutations from haematoxylin and eosin alone — closing the gap for the 25 percent of patients who never reach molecular testing
5 min read
May 25, 2026
By Jessica Allerton
Testing limitations and atypical presentations hinder clinical recognition
4 min read
May 22, 2026
By Jessica Allerton
Why vector-borne diagnostics must evolve with climate and spread
5 min read
May 22, 2026
By Helen Bristow
A veterinary scientist gives the lowdown on transmission and detection of the cruise ship infection
3 min read
May 21, 2026
By Jessica Allerton
How One Health strategies can strengthen diagnostics and public health responses
4 min read
May 20, 2026
Study explores a potential hematological risk marker using real-world data
2 min read
May 14, 2026
By Jessica Allerton
Russ Lebovitz and Arnon Chait on why we need smarter biomarkers to guide clinically actionable diagnostics in an aging population
4 min read
May 13, 2026
Targeted testing may reduce missed diagnoses and future cases
3 min read
May 4, 2026
Global review links particulate matter to multiple cancers and deaths
2 min read
False
False
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
Affiliations:
Specialties:
Areas of Expertise:
False